Compare MGNI & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGNI | LMAT |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | 514 | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.1B |
| IPO Year | 2014 | 2006 |
| Metric | MGNI | LMAT |
|---|---|---|
| Price | $24.00 | $81.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $25.22 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 2.2M | 205.7K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 493.75 | 30.57 |
| EPS | 0.16 | ★ 1.42 |
| Revenue | $156,414,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $6.28 | $14.21 |
| Revenue Next Year | $9.76 | $8.88 |
| P/E Ratio | $150.44 | ★ $56.92 |
| Revenue Growth | ★ 25.45 | 13.53 |
| 52 Week Low | $10.82 | $78.22 |
| 52 Week High | $26.84 | $118.01 |
| Indicator | MGNI | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 49.71 |
| Support Level | $22.44 | $78.65 |
| Resistance Level | $25.53 | $82.45 |
| Average True Range (ATR) | 0.88 | 1.61 |
| MACD | -0.12 | 0.62 |
| Stochastic Oscillator | 25.07 | 95.63 |
Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.